Quote | Super Quote
IPO   |   IPO News   |   Listed IPO Information   |   Hot Listed IPO
Stock Code   IPO News IPO Timetable
IPO Detail
01609 天星醫療
STAR SPORTS MED
Listing Date2026/05/05    Listing Tomorrow
Listing Price98.500
Grey Market Performance
Last updated: 04/05/2026 19:59  Refresh
  • Bright Smart
    up 294.800 +196.300 (+199.289%)
    High
    500.000
     
    Low
    288.000
    Volume
    46,250
    One Lot Profit
    +9,815.00
  • Phillip
    up 290.000 +191.500 (+194.416%)
    High
    601.000
     
    Low
    288.000
    Volume
    474,000
    One Lot Profit
    +9,575.00
  • Futu
    up 309.200 +210.700 (+213.909%)
    High
    501.000
     
    Low
    300.000
    Volume
    749,000
    One Lot Profit
    +10,535.00
  • Bid
  • Ask
  • 294.000
  • (2) 150
  • 100 (2)
  • 294.800
  • 293.800
  • (1) 50
  • 50 (1)
  • 295.000
  • 293.600
  • (0) 0
  • 0 (0)
  • 295.200
  • 293.400
  • (0) 0
  • 0 (0)
  • 295.400
  • 293.200
  • (0) 0
  • 0 (0)
  • 295.600
  • 293.000
  • (1) 50
  • 0 (0)
  • 295.800
  • 292.800
  • (0) 0
  • 50 (1)
  • 296.000
  • 292.600
  • (0) 0
  • 0 (0)
  • 296.200
  • 292.400
  • (0) 0
  • 0 (0)
  • 296.400
  • 292.200
  • (0) 0
  • 0 (0)
  • 296.600
  • Bid
  • Ask
  • 290.000
  • (2) 150
  • 100 (2)
  • 290.400
  •  
  • (0) 0
  • 0 (0)
  •  
  •  
  • (0) 0
  • 0 (0)
  •  
  •  
  • (0) 0
  • 450 (5)
  •  
  •  
  • (0) 0
  • 100 (2)
  •  
 
Hide
COMPANY PROFILE

Star Sports Medicine Co. is a China-based medical device company specializing in clinical sports medicine solutions.

--

The Group is the fourth largest sports medicine implants and instruments provider, representing a market share of approximately 6.5% in China’s sports medicine implants and instruments market, and the largest domestic sports medicine implants and instruments provider in China, in terms of sales revenue in 2024, according to the report.

--

The Group offers holistic solutions for the treatment of injuries to soft tissues of rotator cuffs, ligaments and meniscus at shoulders, knees, hips, feet/ankles, elbows, and hands/wrist, as well as for the rehabilitation and prevention of sports-related injuries, leveraging its self-developed medical implants, active equipment, associated medical consumables and surgical instruments.

--

As of April 15, 2026, the Group’s product portfolio encompassed 63 products spanning medical implants, surgical equipment and associated medical consumables, as well as surgical instruments and regenerative repair products, it had 27 products with Class III medical device certificates and 25 with Class II medical device certificates. As of December 31, 2025, it had cumulatively sold over 2 million units of products.

BASIC INFORMATION
MarketHong Kong (Main Board)
Business NatureHealth Care
Major Business AreaChina
Board Lot50
GLOBAL OFFERING
No. of Offer Shares8.42M H shares
No. of International Offer Shares7.58M H shares
No. of HK Offer Shares0.84M H shares
Offer Price$98.50
Stock Code1609
Sponsor(s)CITIC Securities (Hong Kong) Limited, CCB International Capital Limited
Underwriter(s)CLSA Limited, CCB International Capital Limited, China Galaxy International Securities (Hong Kong) Co., Limited, CMBC Securities Company Limited, Futu Securities International (Hong Kong) Limited, Open Securities Limited, Orient Securities (Hong Kong) Limited, Zheshang International Financial Holdings Co., Limited
TIME TABLE
Application PeriodApr 24 (Fri) - noon, Apr 29 (Wed)
Price Determination Date--
Result Announcement DateOn or before May 04 (Mon)
Result Announcement DateOn or before May 04 (Mon)
Result Announcement DateOn or before May 05 (Tue)
Dealings in Shares commence onMay 05, 2026. (Tue)
Reallocation of Shares Offered
Sales Statistics (HKD)
Offer Price$98.50
Capitalization (H Shares)5.40B
NAV / share ($)$26.80 (Unaudited pro forma adj NAV / share)
Use Of Proceeds
Assuming the offer price being at HKD 98.5, the net proceeds raised would be HKD 758.40M, of which
30% : Expand production capacity and enhance production efficiency
35% : R&D efforts in line with patient-oriented product strategy
25% : Used for commercialization, sales and marketing efforts to reinforce leadership in China and establish presence and brand image worldwide
10% : Working capital
IPO NEWS
04/05/2026 18:35
{New Stock}STAR SPORTS MED ends up 194.42% on grey market
04/05/2026 16:20
{New Stock}STAR SPORTS MED(01609) up 234.82% on grey market
Related Document
Prospectus Prospectus  Chinese VersionProspectus  English Version
Remark： The above information is referenced from the prospectus.
  All data is calculated from the non- exercise rights(if applicable).
IPO Calculator
Name︰
--
--
--
Subscription --
Result Announcement --
Listing --
Offer Price︰--
Currency :
Listing Price :
Board Lot :
Admission Fee*
 :
Subscribing Lot :
Subscribing Fee :
Subscribing Amount :
*Admission fees include brokerage of 1%, SFC transaction levy of 0.0027%, Stock Exchange trading fee of 0.005% and FRC transaction levy of 0.00015% (i.e. 1.0077% in total).
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2026 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.